<DOC>
	<DOCNO>NCT00250432</DOCNO>
	<brief_summary>Comparison safety effectiveness standard drug dose versus daily dose 3 time higher standard dose patient invasive candidiasis ( bloodstream and/or systemic yeast infection )</brief_summary>
	<brief_title>A Multicenter , Randomized , Double-Blind , Comparative Study Evaluate Safety , Tolerability , Efficacy 2 Dosing Regimens Antifungal Drug Treatment Fungal Infections Adults ( 0991-801 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Invasive</mesh_term>
	<mesh_term>Caspofungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<criteria>Clinical Laboratory evidence blood stream &amp; /or systemic candida infection Possible candida contamination Candida colonization ( non invasive infection ) , urine , cardiac , bone brain prosthetic device infection Acute moderately severe liver disease Abnormal liver function test Abnormal blood clot patient blood thinner</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>